CytoDyn Inc (OTCPK:CYDY)
$ 0.1246 -0.0024 (-1.89%) Market Cap: 151.99 Mil Enterprise Value: 159.16 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Cytodyn Inc CytoDyn on Wall Street Reporter with Drs. Pourhassan, Lalezari, and Patterson Transcript

May 21, 2020 / NTS GMT
Release Date Price: $3.17 (+1.60%)
Jack Marks
Wall Street Reporter - Moderator

Good afternoon, everybody, and welcome to Wall Street Reporters NEXT SUPER STOCK Livestream for today, May 13th, 2020, and we're proud to bring you another special presentation, [with a] special update from CytoDyn, stock symbol, of course, is CYDY, which many of you have been following since August, since they first presented at our livestream. The company has been making tremendous progress (technical difficulty) exciting news now with the coronavirus treatment. And we're going to be hearing more about that today with the latest data.

And again, CytoDyn is a perfect example of what that next super stock series is all about, which is bringing new stocks with 10x upside potential. So the format for today's simple. Dr. Nader Pourhassan is going to present. Then we'll -- I think you'll be joined by Dr. Bruce Patterson and Dr. Jay Lalezari. I always mispronounce, I apologize. And then we'll open up for the questions. We got a lot of questions. We got over 400 questions that came in. Hopefully, we will answer some of them. So with that being said, please

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot